Medically reviewed by Majesta Health Medical Review Team

Compounded Semaglutide: The 2026 Complete Guide

Compounded semaglutide is a preparation that contains semaglutide, made by a state-licensed compounding pharmacy under a physician prescription. It is not FDA-approved as a final product and is not a generic version of, equivalent to, or interchangeable with any FDA-approved medication. It is most commonly used for chronic weight management in adults. This 2026 guide explains how it works, what it costs, whether it is safe, how it is regulated, and how to access it legally through US telehealth.

Last reviewed: 2026-05-31. Updated quarterly or when clinical guidance materially changes.

1. What is compounded semaglutide?

Compounded semaglutide is a preparation that contains semaglutide, made by a state-licensed compounding pharmacy under a prescription written by a licensed physician for an individual patient. Compounding is the regulated practice of preparing customized medications based on a physician order, and the framework is governed by Section 503A of the Federal Food, Drug, and Cosmetic Act for patient-specific prescriptions and Section 503B for outsourcing facilities.

Compounded semaglutide is not FDA-approved as a final product and is not a generic version of, equivalent to, or interchangeable with any FDA-approved medication. Compounded preparations have not been the subject of their own clinical trials; the dose, the plan, and realistic expectations are set by the prescribing physician, and individual results vary.

Plain-English summary

Compounded semaglutide is a preparation that contains semaglutide, made by a licensed compounding pharmacy and prescribed by a physician for an individual patient. It is not FDA-approved as a final product and is not a generic version of any FDA-approved medication.

2. FDA-approval status: what compounding means legally

FDA approval applies to a specific finished drug product made by a specific manufacturer: its formulation, manufacturing process, labeling, and clinical trial evidence are reviewed and approved as a package. Compounded medications sit in a different legal category. They are prepared by a state-licensed compounding pharmacy for an individual patient under a physician prescription, as permitted by Section 503A of the Federal Food, Drug, and Cosmetic Act, and the finished preparation itself is not reviewed or approved by the FDA.

Three practical consequences follow. First, compounded semaglutide is not FDA-approved as a final product. Second, it is not a generic: a generic drug goes through its own FDA review demonstrating equivalence to a reference product, and no compounded preparation does that. Third, it is not equivalent to or interchangeable with any FDA-approved medication, and clinical trial results generated by FDA-approved products do not describe compounded preparations.

Oversight of compounding comes from state boards of pharmacy, which license and inspect compounding pharmacies, and from United States Pharmacopeia standards (USP 795 and 797) that govern how preparations are made. A prescription from a licensed physician for an identified individual patient is required in every case.

Compounded medications are not FDA-approved as final products and are not generic versions of, equivalent to, or interchangeable with any FDA-approved medication. Compounded GLP-1 medications are prepared by state-licensed compounding pharmacies based on a physician's prescription for an individual patient. Brand names such as Ozempic®, Wegovy®, Mounjaro®, and Zepbound® are separate FDA-approved products manufactured by their respective companies and are referenced here for educational comparison only. Results may vary. Not a substitute for professional medical advice.

3. How compounded semaglutide works

Semaglutide is a GLP-1 receptor agonist. It mimics glucagon-like peptide-1, a hormone the gut releases in response to food, and it acts on three systems that drive appetite, eating behavior, and glycemic control:

  • Slows gastric emptying. Food remains in the stomach longer, increasing satiety per meal.
  • Suppresses appetite at the hypothalamus. Reduces the drive to seek food between meals.
  • Improves insulin secretion in response to glucose. Helps control post-meal glucose spikes.

The result is reduced caloric intake without active willpower work, alongside better post-meal blood sugar control. No clinical trials have been conducted on compounded semaglutide itself, so we do not quote efficacy figures for it. Your prescribing physician sets the dose and realistic expectations for your case, and outcomes in real world practice vary based on dose, adherence, diet, activity, and other medical factors.

4. Compounded semaglutide cost in 2026

At Majesta Health, compounded semaglutide injection (the Essential plan) is $179 your first month, then $299 a month. One price includes the physician consultation, the medication, and shipping. A $20 medical consultation fee is included in your first month, collected on a pass-through basis to the prescribing provider where applicable. Cancel anytime.

Flagship plan

Essential

Compounded semaglutide injection

$179 first month

Then $299 per month

See Essential details

Tirzepatide

Performance

Compounded tirzepatide injection

$339 first month

Then $439 per month

See Performance details

Both plans include physician consultation, compounded medication, discreet shipping, and unlimited messaging with your care team. Cancel anytime.

What is actually in your monthly price?

  • Physician evaluation and ongoing care
  • Compounded medication from a US-licensed compounding pharmacy
  • Discreet, temperature-controlled shipping
  • Unlimited messaging with the care team
  • A $20 medical consultation fee where applicable, collected on a pass-through basis to the prescribing provider

For a deeper cost breakdown, including hidden fees to watch for at other providers, read our full compounded semaglutide cost guide and our cheapest semaglutide online comparison.

5. Is compounded semaglutide safe?

Compounded semaglutide prepared by a properly licensed and inspected pharmacy uses a pharmaceutical-grade active ingredient and follows United States Pharmacopeia standards. Compounded semaglutide is not FDA-approved as a final product and is not interchangeable with brand-name semaglutide. Safety in practice depends on three independent things: pharmacy quality, physician evaluation, and honest patient disclosure.

What good pharmacy quality looks like

  • Active state pharmacy license
  • NABP (National Association of Boards of Pharmacy) accreditation
  • LegitScript Healthcare Merchant Certification
  • Compliance with USP 795 (non-sterile compounding), USP 797 (sterile compounding), USP 800 (hazardous drugs) where applicable
  • Pharmaceutical-grade active ingredient sourcing to USP standards
  • Clean recent state Board of Pharmacy inspection history

What good physician evaluation looks like

  • Reviews complete medical history, current medications, and goals before writing a prescription
  • Screens for contraindications including medullary thyroid carcinoma history, MEN 2, pancreatitis, type 1 diabetes, pregnancy and conception plans, and severe gastrointestinal disease
  • Holds a license in the patient's state of residence
  • Provides ongoing care, not a one-time evaluation
  • Has clear escalation paths for adverse events

For a deeper safety review including data from FDA adverse event reports, read our full 2026 safety analysis.

7. Who is a candidate for compounded semaglutide?

The candidacy question is decided by a licensed physician based on your complete medical history. The general clinical pattern, drawn from FDA labeling and major trials, is:

Typically appropriate for evaluation

  • Adults with a BMI of 30 or higher
  • Adults with a BMI of 27 or higher and at least one weight-related comorbidity such as type 2 diabetes, hypertension, dyslipidemia, or obstructive sleep apnea
  • Patients who have not achieved their goals with diet and lifestyle alone

Typically not appropriate

  • Personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 (MEN 2)
  • History of severe hypersensitivity to semaglutide
  • Active pancreatitis
  • Type 1 diabetes
  • Active pregnancy, attempts to conceive, or breastfeeding
  • Eating disorders (active or history)
  • Under 18 years of age

People with diabetic retinopathy, history of severe gastrointestinal disease, moderate to severe kidney impairment, or any complex medication regimen require careful physician evaluation before starting. Always disclose your full medical history and every medication and supplement during your assessment.

8. How to get compounded semaglutide online

US telehealth platforms have streamlined the path significantly. At Majesta Health, the standard flow is five steps:

  1. Step 1

    Complete a 2-minute medical assessment

    Confirm your state, goals, and medical history. Mississippi and Louisiana residents are routed to a waitlist because our clinician network does not currently serve those states.

  2. Step 2

    Consent to telehealth services

    Review and accept our telehealth informed consent. This is a required step before any clinical evaluation.

  3. Step 3

    Physician review

    A US-licensed physician from MD Integrations, our telehealth provider group partner, reviews your file. If you are a candidate, they write the prescription. If you are not, they explain why and refer you to alternatives.

  4. Step 4

    Pharmacy fills your prescription

    Our partner compounding pharmacy (LegitScript Healthcare Merchant Certified, NABP accredited) prepares your monthly supply.

  5. Step 5

    Discreet shipping and ongoing care

    Temperature-controlled shipping to your door. Unlimited messaging with the care team for questions, dose adjustments, and side effect support.

For a deeper walkthrough including what to expect at each step, read our online GLP-1 prescription guide.

9. Compounded semaglutide provider red flags

The compounded GLP-1 market grew quickly between 2022 and 2025. Most providers are legitimate. Some are not. Walk away from any provider that does one of the following:

  • Promises specific pounds lost or specific clothing sizes
  • Ships medication without a physician evaluation, or claims no prescription is required
  • Markets the medication as FDA-approved, or hides the compounded status
  • Does not name its partner compounding pharmacy or refuses to confirm LegitScript and NABP status
  • Uses fake before-and-after photos or testimonials that look stock or copied from other sites
  • Prices that are far below the market range without a transparent explanation, especially below $99 per month for injectable semaglutide
  • No physical business address, no phone number, and no clear ownership disclosure
  • Pressures one-click upsells before a physician has even reviewed your case

10. Compounded semaglutide dosing schedule

Semaglutide is titrated upward gradually to manage side effects. The standard injection schedule used in clinical trials and adapted by most US telehealth providers is:

PhaseDose (injection)Purpose
Month 10.25 mg weeklyTolerance building
Month 20.5 mg weeklyFirst clinical effect
Month 31.0 mg weeklySteady appetite reduction
Month 4+1.7 mg weeklyStronger maintenance effect
Month 5+Up to 2.4 mg weekly as toleratedMaximum maintenance dose

Sublingual semaglutide titration is different: typically 1 mg daily for days 1 to 14, 2 mg daily from day 15 onward, and up to 3 mg daily during maintenance based on response and tolerance. The prescribing physician sets your actual schedule based on your medical profile.

Do not change your dose without talking to your physician. Skipping doses or doubling up to catch up creates unnecessary side effects without improving outcomes.

11. Side effects of compounded semaglutide

The most commonly reported side effects of semaglutide are gastrointestinal and tend to peak during dose escalation and improve over weeks.

Common (typical of dose increases)

  • Nausea (most common)
  • Vomiting
  • Diarrhea or constipation
  • Decreased appetite (intended effect)
  • Mild fatigue
  • Headache
  • Reflux or abdominal discomfort

Less common but more serious

  • Pancreatitis (severe abdominal pain that radiates to the back)
  • Gallbladder disease, including gallstones
  • Severe hypoglycemia, especially in patients also taking insulin or sulfonylureas
  • Acute kidney injury from dehydration
  • Allergic reactions
  • Changes in diabetic retinopathy in patients with that condition

Contact your prescribing physician for symptoms that persist beyond expected adjustment windows or that are severe. Seek emergency care for symptoms suggesting pancreatitis, severe allergic reaction, severe dehydration, or severe hypoglycemia. For practical management tips, see our semaglutide side effects guide.

12. Compounded semaglutide vs other GLP-1 options

Compounded semaglutide is one of several GLP-1 options patients consider in 2026. The two most common comparisons:

Sublingual semaglutide

A daily oral troche that dissolves under the tongue. Some patients prefer this form because it avoids weekly self-injection. Bioavailability and titration differ from the injectable form. Read our sublingual semaglutide guide for the full picture.

Compounded tirzepatide

Compounded tirzepatide contains tirzepatide, a dual GIP and GLP-1 receptor agonist, meaning it acts on two gut hormone pathways instead of one. It is available through some US telehealth providers and is typically priced higher than compounded semaglutide. At Majesta Health it is offered as the Performance plan. See our tirzepatide vs semaglutide comparison for how the two ingredients differ.

13. Frequently asked questions

What is compounded semaglutide?

Compounded semaglutide is a preparation that contains semaglutide, made by a state-licensed compounding pharmacy based on a prescription written by a licensed physician for an individual patient. The finished compounded preparation is not FDA-approved as a final product and is not a generic version of, equivalent to, or interchangeable with any FDA-approved medication. This not-FDA-approved status applies to all properly compounded medications under Section 503A of the Federal Food, Drug, and Cosmetic Act.

How much does compounded semaglutide cost in 2026?

At Majesta Health, the semaglutide injection plan (Essential) is $179 your first month and $299 a month after. One price includes the physician consultation, the medication, and shipping. A $20 medical consultation fee is included in your first month, collected on a pass-through basis to the prescribing provider. Cancel anytime.

Is compounded semaglutide safe?

Compounded semaglutide prepared by a properly licensed and inspected compounding pharmacy uses a pharmaceutical-grade active ingredient and follows United States Pharmacopeia standards (USP 795, 797, 800 as applicable). Safety depends on three things: the pharmacy's licensure and inspection record, the prescribing physician's evaluation of your medical history, and your honest reporting of conditions and medications. Commonly reported side effects of semaglutide include nausea, decreased appetite, fatigue, and gastrointestinal discomfort. Always disclose pregnancy plans, personal or family history of medullary thyroid cancer or MEN 2, pancreatitis, and any GLP-1 medications you have taken in the past.

Is compounded semaglutide FDA-approved?

No compounded medication is FDA-approved as a final product, and compounded semaglutide is not a generic version of, equivalent to, or interchangeable with any FDA-approved medication. Properly compounded preparations are produced legally under Section 503A of the Federal Food, Drug, and Cosmetic Act when prepared for an individual patient based on a prescription from a licensed physician.

How do I get compounded semaglutide online?

Through licensed telehealth platforms, the typical flow is: complete an online medical assessment, consent to telehealth services, have your file reviewed by a US-licensed physician in your state, fill a prescription at a partner compounding pharmacy, and receive monthly shipments to your door. At Majesta Health, the assessment takes about two minutes and you only proceed if your file qualifies you for care.

How long does it take to see results with compounded semaglutide?

Most patients begin noticing appetite reduction within the first two to four weeks of starting treatment, during the early titration phase. Meaningful weight changes typically appear by month three and continue through months six to twelve as the maintenance dose is reached. Compounded semaglutide has not been the subject of its own clinical trials; your physician sets the dose and realistic expectations for your case. Individual results vary based on dose, adherence, diet, activity level, and other medical factors.

What is the standard dosing schedule for compounded semaglutide?

The standard semaglutide titration starts low and increases gradually to reduce side effects. A common schedule is 0.25 mg per week for month one, 0.5 mg per week for month two, 1.0 mg per week for month three, and 1.7 to 2.4 mg per week thereafter as tolerated. The prescribing physician adjusts the schedule based on your response, side effects, and goals. Do not change your own dose without medical guidance.

Who should not take compounded semaglutide?

Semaglutide is not appropriate for people with a personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2 (MEN 2), known severe hypersensitivity to semaglutide, active pancreatitis, type 1 diabetes, current pregnancy or active attempts to conceive, or breastfeeding. People with a history of severe gastrointestinal disease, diabetic retinopathy, or moderate to severe kidney impairment require careful physician evaluation before starting. Always disclose your full medical and medication history during the assessment.

What are the most common side effects of compounded semaglutide?

The most common side effects are gastrointestinal: nausea, vomiting, diarrhea, constipation, abdominal pain, and decreased appetite. These tend to be strongest during dose escalation and improve over weeks. Less common but more serious side effects include pancreatitis, gallbladder problems, severe hypoglycemia (especially in people also taking insulin or sulfonylureas), kidney injury from dehydration, allergic reactions, and changes in diabetic retinopathy. Contact your provider for symptoms that do not improve or are severe.

Can I stop compounded semaglutide once I reach my goal?

Stopping any GLP-1 medication abruptly often leads to appetite return and, for many people, partial weight regain over time. That is why discontinuation should be a plan, not an event. A licensed physician can help you build a maintenance plan, which may include reduced dosing, monitored discontinuation, lifestyle support, or transition to a long-term plan based on your goals.

Is compounded semaglutide covered by insurance?

Compounded medications are generally paid out of pocket and not covered by commercial insurance plans. HSA and FSA accounts can usually be used for the medical consultation portion when prescribed by a licensed physician for a covered condition. Confirm with your plan administrator.

What is the difference between sublingual and injectable compounded semaglutide?

Injectable semaglutide is administered subcutaneously once per week and is the dosing form used in all major clinical trials. Sublingual semaglutide is a compounded oral troche that dissolves under the tongue, typically taken daily on an empty stomach. Some patients prefer sublingual because it avoids weekly self-injection. Bioavailability profiles differ between the two routes; your prescribing physician will recommend the formulation that fits your medical history, preferences, and goals.

Can I take compounded semaglutide with other weight loss medications?

Combining GLP-1 medications with other weight loss drugs, supplements, or other GLP-1 medications is not appropriate without explicit physician guidance because of overlapping mechanisms and increased risk of low blood sugar, dehydration, and gastrointestinal side effects. Disclose every medication and supplement you take during your assessment.

How is compounded semaglutide shipped and stored?

Injectable compounded semaglutide ships in temperature-controlled packaging and is typically stored refrigerated between 36 and 46 degrees Fahrenheit. Sublingual troches are typically stored at controlled room temperature in the original packaging away from light and humidity. Follow the storage instructions on the pharmacy label, which take precedence over general guidance.

How do I know a compounded semaglutide provider is legitimate?

Look for these signals: a named US-licensed physician network, a named partner compounding pharmacy that holds LegitScript Healthcare Merchant Certification and NABP accreditation, transparent pricing and disclosure language, a written telehealth informed consent, clear medical assessment with state restriction enforcement, no specific weight loss guarantees, no fake testimonials, and a real physical business address. Avoid providers that promise specific weight loss, ship without a physician evaluation, or advertise prices that look impossibly low.

14. Sources and references

This guide reflects publicly available information as of 2026-05-31. It is educational and does not substitute for personalized medical advice. Compounded medications are not FDA-approved as final products and are not generic versions of, equivalent to, or interchangeable with any FDA-approved medication. Compounded GLP-1 medications are prepared by state-licensed compounding pharmacies based on a physician's prescription for an individual patient. Brand names such as Ozempic®, Wegovy®, Mounjaro®, and Zepbound® are separate FDA-approved products manufactured by their respective companies and are referenced here for educational comparison only. Results may vary. Not a substitute for professional medical advice.

Reserve your founding-member spot

Founding members get priority access, locked-in pricing, and a dedicated US-licensed physician when we open.

Start Your Assessment

Compounded medications are not FDA-approved as final products and are not generic versions of, equivalent to, or interchangeable with any FDA-approved medication. Compounded GLP-1 medications are prepared by state-licensed compounding pharmacies based on a physician's prescription for an individual patient. Brand names such as Ozempic®, Wegovy®, Mounjaro®, and Zepbound® are separate FDA-approved products manufactured by their respective companies and are referenced here for educational comparison only. Results may vary. Not a substitute for professional medical advice.